Skip to content

Evaluation for chemotherapy-induced myocardial injury with 18F-FDG PET/CT radiomics

Evaluation for chemotherapy-induced myocardial injury with 18F-FDG PET/CT radiomics

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022819
Enrollment
Unknown
Registered
2019-04-27
Start date
2019-05-01
Completion date
Unknown
Last updated
2019-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chemotherapy-induced myocardial injury

Interventions

Gold Standard:pathology for the confirmation of malignant tumor
conventional diagnostic strategy (combined analysis of echocardiography, myocardial enzyme, electrocardiogram, etc.) for diagnosing myocardial injury
imaging

Sponsors

Beijing Chao-Yang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: Part one: (1) normal control group: no history of malignant tumor, no elevated tumor markers, and no definite abnormal findings on PET/CT imaging; (2) untreated cancer group: newly diagnosed malignant patients based on pathology within one month of PET/CT imaging, and no tumor-related treatment was initialed; (3) post-chemotherapy group: malignant patient with definite diagnosis who has completed chemotherapy, and the chemotherapy regimen contains at least one kind of adriamycin. Part two: (1) patients will be selected from the malignant patients admitted to Beijing Chaoyang Hospital from 2019.01 to 2020.12; (2) patients had newly diagnosed malignant tumors by pathology within one month of PET/CT imaging, without any tumor-related treatment; (3) patients were scheduled for chemotherapy according to the relevant guidelines and the chemotherapy regimen includes adriamycin drugs; (4) patients hve no previous history of heart disease, no clinical manifestations related to heart disease, and relevant examinations revealed no cardiovascular diseases; (5) patients have no other serious complications; (6) patients sign the informed consent and agreed to participate in the study.

Exclusion criteria

Exclusion criteria: All of the included patients in the two series have no the fololowing conditions: 1. The fasting time for PET/CT imaging was less than 12 hours; 2. Have a history of cardiovascular disease or other serious complications.

Design outcomes

Primary

MeasureTime frame
LVEF;myocardial enzyme;Myocardial SUV;Uptake patterns of left ventricular;

Countries

China

Contacts

Public ContactMin-Fu Yang

Beijing Chao-Yang Hospital, Capital Medical University

minfuyang@126.com+86 13501009189

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026